Medical Developments International Ltd (ASX: MVP) Share Price and News

Price
Movement
52 Week Range
1 Year Return
() Chart and Price Data
Fundamental Company Figures
Data provided by Morningstar.Medical Developments International Ltd (ASX: MVP) Latest News
Will the Medical Developments share price recover?
Aaron Teboneras | September 2, 2020 6:07pm
Medical Developments International share price tumbles on FY 2020 profit decline
James Mickleboro | August 20, 2020 5:52pm
Why the Medical Developments International share price jumped 14% higher today
James Mickleboro | August 19, 2020 10:36am
3 junior ASX healthcare shares with explosive growth potential
Rhys Brock | July 27, 2020 10:36am
Why this underperforming ASX healthcare company could still light up the market in 2020 and beyond
Rhys Brock | July 23, 2020 4:47pm
Why the Nearmap share price and one other are on my buy list
Michael Tonon | June 13, 2020 10:30am
Dividend Payment History
Data provided by Morningstar.Ex-Date | Amount | Franking | Type | Payable |
---|---|---|---|---|
05 Mar 2020 | $0.0200 | 100.00% | Interim | 17 Apr 2020 |
03 Sep 2019 | $0.0200 | 100.00% | Final | 04 Oct 2019 |
07 Mar 2019 | $0.0200 | 100.00% | Interim | 17 Apr 2019 |
30 Aug 2018 | $0.0200 | 100.00% | Final | 05 Oct 2018 |
02 Mar 2018 | $0.0200 | 100.00% | Interim | 13 Apr 2018 |
31 Aug 2017 | $0.0200 | 100.00% | Final | 06 Oct 2017 |
03 Mar 2017 | $0.0200 | 100.00% | Interim | 10 Apr 2017 |
01 Sep 2016 | $0.0200 | 100.00% | Final | 07 Oct 2016 |
02 Mar 2016 | $0.0200 | 100.00% | Interim | 08 Apr 2016 |
02 Sep 2013 | $0.0200 | 100.00% | Final | 11 Oct 2013 |
27 Feb 2013 | $0.0300 | 100.00% | Interim | 11 Apr 2013 |
28 Feb 2012 | $0.0300 | 100.00% | Interim | 11 Apr 2012 |
31 Aug 2011 | $0.0300 | 100.00% | Final | 10 Oct 2011 |
Yearly Dividend Payment Chart
Data provided by Morningstar.About Medical Developments International Ltd (ASX: MVP)
Medical Developments International Ltd is a specialized healthcare company. It manufactures and distributes the pharmaceutical drug and medical and veterinary equipment. The company provides a range of products in the areas of pain management, asthma, and resuscitation, plus veterinary equipment. It is organized into three business units: Pharmaceuticals, Medical Devices, and Veterinary products. Majority of its revenue comes from Pharmaceuticals Unit which engages in the sale of Penthrox primarily within Australia, New Zealand, Europe the UK and some sales in Canada, the Middle East, Asia and South Africa.
Share Price History
Data provided by Morningstar.Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
18 Jan 2021 | $6.66 | $-0.14 | -2.06% | 99,380 | $6.80 | $6.84 | $6.52 |
15 Jan 2021 | $6.80 | $0.05 | 0.74% | 97,397 | $6.65 | $6.80 | $6.63 |
14 Jan 2021 | $6.75 | $0.07 | 1.05% | 151,534 | $6.68 | $6.88 | $6.63 |
13 Jan 2021 | $6.68 | $0.17 | 2.61% | 116,792 | $6.50 | $6.68 | $6.48 |
12 Jan 2021 | $6.51 | $0.01 | 0.15% | 88,265 | $6.51 | $6.56 | $6.47 |
11 Jan 2021 | $6.50 | $0.19 | 3.01% | 154,750 | $6.32 | $6.50 | $6.18 |
08 Jan 2021 | $6.31 | $-0.01 | -0.16% | 51,805 | $6.30 | $6.45 | $6.30 |
07 Jan 2021 | $6.32 | $-0.06 | -0.94% | 170,040 | $6.38 | $6.42 | $6.10 |
06 Jan 2021 | $6.38 | $-0.12 | -1.85% | 155,086 | $6.49 | $6.50 | $6.33 |
05 Jan 2021 | $6.50 | $-0.14 | -2.11% | 134,789 | $6.60 | $6.60 | $6.46 |
04 Jan 2021 | $6.64 | $-0.04 | -0.60% | 66,993 | $6.62 | $6.64 | $6.55 |
31 Dec 2020 | $6.68 | $-0.02 | -0.30% | 39,089 | $6.65 | $6.71 | $6.58 |
30 Dec 2020 | $6.70 | $0.00 | 0.00% | 27,756 | $6.70 | $6.76 | $6.63 |
29 Dec 2020 | $6.70 | $-0.01 | -0.15% | 63,747 | $6.71 | $6.74 | $6.57 |
24 Dec 2020 | $6.71 | $-0.10 | -1.47% | 76,939 | $6.80 | $6.87 | $6.71 |
23 Dec 2020 | $6.81 | $0.14 | 2.10% | 199,872 | $6.66 | $6.89 | $6.58 |
22 Dec 2020 | $6.67 | $-0.01 | -0.15% | 127,005 | $6.70 | $6.78 | $6.57 |
21 Dec 2020 | $6.68 | $-0.06 | -0.89% | 165,334 | $6.73 | $6.90 | $6.61 |
Director Transactions
Data provided by Morningstar.Directors & Management
Data provided by Morningstar.Top Share Holders
Data provided by Morningstar.Name | Shares | Capital |
---|---|---|
Mr David John Williams | 9,650,782 | 14.71% |
HSBC Custody Nominees | 6,685,759 | 10.19% |
J P Morgan Nominees Australia | 4,249,171 | 6.48% |
Citicorp Nominees Pty Limited | 3,319,510 | 5.06% |
Netwealth Investments Limited | 1,620,522 | 2.47% |
Dr Russell Kay Hancock | 1,614,214 | 2.46% |
Sandhurst Trustees | 1,053,413 | 1.61% |
Ubs Nominees | 874,242 | 1.33% |
National Nominees Limited | 712,776 | 1.09% |
Mr Alistair David Strong | 630,000 | 0.96% |
Warbont Nominees Pty Ltd | 532,983 | 0.81% |
Mrs Virgina Catherine Hancock | 518,487 | 0.79% |
Cs Fourth Nominees | 507,331 | 0.77% |
Jj Opperman Superannuation Pty Limited | 300,000 | 0.46% |
Pnsf Pty Ltd | 264,565 | 0.40% |
Mr Michael Clifford Hickling & Mrs Giovanna Hickling | 255,936 | 0.39% |
Imaj Pty Ltd | 253,750 | 0.39% |
Capricorn Investment Partners (Nominees) Pty Ltd | 250,000 | 0.38% |
BNP Paribas Nominees Pty Ltd | 215,940 | 0.33% |
Hollywind Pty Ltd | 200,000 | 0.30% |